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ReviewSex differences in obesity, lipid metabolism, and
inflammationdA role for the sex chromosomes?Temeka Zore, Maria Palafox, Karen Reue*ABSTRACT
Background: Sex differences in obesity and related diseases are well established. Gonadal hormones are a major determinant of these sex
differences. However, sex differences in body size and composition are evident prior to exposure to gonadal hormones, providing evidence for
gonadal-independent contributions attributable to the XX or XY sex chromosome complement. Large-scale genetic studies have revealed male/
female differences in the genetic architecture of adipose tissue amount and anatomical distribution. However, these studies have typically
neglected the X and Y chromosomes.
Scope of the review: Here we discuss how the sex chromosome complement may influence obesity, lipid levels, and inflammation. Human sex
chromosome anomalies such as Klinefelter syndrome (XXY), as well as mouse models with engineered alterations in sex chromosome com-
plement, support an important role for sex chromosomes in obesity and metabolism. In particular, the Four Core Genotypes mouse mod-
eldconsisting of XX mice with either ovaries or testes, and XY mice with either ovaries or testesdhas revealed an effect of X chromosome
dosage on adiposity, hyperlipidemia, and inflammation irrespective of male or female gonads. Mechanisms may include enhanced expression of
genes that escape X chromosome inactivation.
Major conclusions: Although less well studied than effects of gonadal hormones, sex chromosomes exert independent and interactive effects
on adiposity, lipid metabolism, and inflammation. In particular, the presence of two X chromosomes has been associated with increased adiposity
and dyslipidemia in mouse models and in XXY men. The enhanced expression of genes that escape X chromosome inactivation may contribute,
but more work is required.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords Genetics; Gonadal hormones; Adipose tissue; Sex chromosome anomalies; X chromosome inactivation; Mouse models1. SEXUAL DIMORPHISM IN DISEASE
The study of sex differences in physiology has gained traction as it
pertains to understanding male/female differences in disease sus-
ceptibility. Women more often than men suffer from autoimmune
diseases (e.g., systemic lupus erythematosus, scleroderma, Sjogren’s
syndrome), as well as osteoporosis, Alzheimer’s disease, and clinical
depression [1e6]. Autism occurs at higher rates in boys than girls, and
sex differences are also observed in neurological diseases such as
Parkinson’s disease and schizophrenia, to name a few [7e9]. In
cardiovascular disease and stroke, there are differences between the
sexes in age of onset, disease pathology, and mortality [10].
Some sex differences in human disease are directly related to the
distinct sex chromosome complement in females (XX) and males (XY).
Males are more commonly afflicted with X-linked diseases such as
color blindness, Duchenne muscular dystrophy, and hemophilia.
Women may be protected from (or experience attenuated severity of)
these recessive disorders, because they possess two X chromosomes
[11]. The random inactivation of one X chromosome in female cells
during early development silences the X chromosome carrying a
mutant gene in approximately half of female cells, allowing theDepartment of Human Genetics, David Geffen School of Medicine at the University of
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example of the influence of XX versus XY genotype on disease severity
is Rett syndrome, which results from mutation in the MECP2 gene on
the X chromosome. Females afflicted with Rett mutations experience
progressive neuro-developmental deficiencies leading to impaired
learning, communication, coordination, and other brain functions. By
contrast, males with MECP2 mutations typically die in utero or in in-
fancy [12].
Here we will discuss how the sex chromosome complement may
influence factors that underlie metabolic disturbances such as
obesity, dyslipidemia, and inflammation. It is well known that gonadal
hormones have strong effects on fat storage and susceptibility to
related diseases such as cardiovascular disease and type 2 diabetes
[13]. Since female gonads are typically found together with XX
chromosomes, and male gonads with XY chromosomes, the inde-
pendent roles of gonadal hormones and sex chromosomes has not
been appreciated. However, human sex chromosome anomalies such
as Klinefelter syndrome (XXY) and Turner syndrome (XO), as well as
mouse models with engineered alterations in sex chromosome
complement, support an important role for sex chromosomes in
obesity and metabolism.California, Los Angeles, Los Angeles, CA 90095, USA
man Genetics, Gonda 6357B, 695 Charles E. Young Drive South, Los Angeles, CA
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Review2. SEX DIFFERENCES IN HUMAN ADIPOSITY AND OBESITY
Adipose tissue serves as an efficient energy storage depot. It also has
active roles in fatty acid uptake from circulating lipoproteins produced
in response to a meal, and in the regulated release of fatty acids for use
by other tissues between meals or during physical activity. There are
key differences between males and females in adipose tissue distri-
bution, with men accumulating greater amounts of visceral adipose
tissue and women typically having greater fat accumulation in sub-
cutaneous (glutealefemoral) depots [14,15]. Sex-specific fat distri-
bution is influenced by several factors, including diet and hormonal
status [16]. One contributor to sex bias in adipose tissue distribution
may be the rate of direct fatty acid uptake by tissues, a process that
occurs independently of lipoprotein lipase (the enzyme responsible for
liberation of fatty acids from lipoproteins). Direct fatty acid uptake is
higher in the glutealefemoral depot in women and in the abdominal
depot in men [17].
Both overall fat mass and visceral fat accumulation are strongly
associated with the development of cardiovascular disease, stroke,
hypertension, and insulin resistance [15,18,19]. Standard mea-
surements for fat accumulation in humans include body mass index
(weight as a function of height), which reflects whole body
adiposity, and waist-to-hip ratio, which provides an indication of fat
distribution, with the waist measurement as a proxy for visceral fat
and the hip measurement for gluteal fat [19]. Seminal studies
performed in the 1980’s provided evidence that overall adiposity, as
well as subcutaneous fat mass, have a heritability of approximately
30% [20]. This estimate was corroborated by a 1990 study in
Caucasian male twins that showed a 31% heritability of waist-to-hip
ratio, while a more recent population-based study estimated heri-
tability of the same trait at 39% [21,22]. Some estimates indicate
that heritability of fat distribution is greater in women than in men
[19]. Fat distribution and heritability also differ across ethnic groups
[23,24]. One approach to identify the genes contributing to sex
differences in adipose tissue accumulation and distribution is
genome-wide association studies (GWAS) in large human cohorts.
This approach types genetic variants across the genome and cor-
relates their occurrence with a trait to identify loci that are asso-
ciated. GWAS performed in hundreds of thousands of people have
identified more than 100 genetic loci that harbor common genetic
variants that influence adiposity [25e27]. Importantly, at least 17
loci that are associated with body mass index have also been
identified in GWAS for type 2 diabetes [25].
Analysis of accumulated GWAS data has revealed a distinct genetic
architecture for loci affecting adiposity in males and females. For
example, a meta-analysis of more than 50 GWAS studies with
waist-to-hip ratio (adjusted for total fat) in more than 200,000 in-
dividuals identified 49 loci, 20 of which showed sex-specific effects,
with 19 of these having stronger effects in women [28]. These loci
represent a rich resource for the identification of sex-biasing genetic
factors for body composition and fat distribution, although at pre-
sent, these loci together account for only a few percent of the
genetic variance in adiposity. Much work remains to be done,
including the identification of the causal variants at each locus and
their mechanism of action to influence adiposity. Of note, these
analyses did not take into account loci on the X or Y chromosomes,
leaving a gap in our knowledge regarding how genetic variations on
X and Y may contribute to observed sex differences in adiposity. The
following sections describe studies outside of GWAS that have
informed about the role of the X and Y chromosomes in adiposity
and metabolic disease.36 MOLECULAR METABOLISM 15 (2018) 35e44  2018 The Authors. Published by Elsevier GmbH. T3. SEX DIFFERENCES IN ADIPOSE TISSUE EXPANSION
It has been suggested that adipocytes in glutealefemoral depots (and
other subcutaneous depots) confer better metabolic health because of
the ability to expand to store more fat by recruiting new adipocytes
[16,29,30]. It has previously been thought that male mice exhibit
greater diet-induced fat mass expansion (in both visceral and subcu-
taneous depots) than females, and this is partly due to effects of sex
hormones [31e33]. However, a recent study demonstrates that in
C57BL/6J mice, the sex differences in diet-induced weight gain
depend strongly on the age of the mice when fed a high fat diet. In
juvenile mice (aged 6 weeks), feeding a high-fat diet for 3 months led
to greater percent weight gain in males than females. However, in
adult mice (aged 31 weeks), the trend was reversed, and females
gained substantially greater percent body weight in response to high-
fat diet [34].
One potential contributor to sex differences in adipose tissue expansion
is the numbers of adipocyte precursor cells (pluripotent stem cells that
may differentiate into adipocytes, chondrocytes or osteoblasts) in
mouse gonadal or subcutaneous fat depots. On a low-fat chow diet,
female C57BL/6J mice have more adipocyte precursor cells than
males in gonadal (visceral) and inguinal (subcutaneous) fat pads [35e
37]. When fed a high-fat diet (45% calories as fat), female mice
showed increased adipocyte precursor cells and mature adipocytes in
gonadal fat, but males did not increase mature fat cells in the gonadal
fat pad [36]. Other studies, which employed pulse-labeling or lineage
tracing to follow the fate of proliferating adipocyte progenitor cells,
inferred that male gonadal fat exhibits hyperplasia in response to a
high-fat diet, whereas females exhibit adipocyte hyperplasia in both
gonadal and subcutaneous fat depots [38,39]. The sex-specific pat-
terns were reversed by ovariectomy in female mice, or estrogen
administration in male mice, suggesting a role for gonadal hormones
[37]. These studies have proved valuable, but additional studies of
adipocyte recruitment and turnover in fat depots of both sexes are
needed to clarify discrepancies between studies that have used distinct
methodologies and to provide additional details.
4. GONADAL AND CHROMOSOMAL INFLUENCES ON ADIPOSITY
Gonadal hormones have major effects on fat storage and related
diseases, as evidenced by comparisons of pre-menopausal and post-
menopausal women. After menopause and reduction in the levels of
estrogen and other gonadal hormones, women typically experience
increased fat storage in abdominal depots, and an increased occur-
rence of cardiovascular diseases, hyperlipidemia, insulin resistance,
and hypertension [14,40e43]. However, short-term reduction in es-
trogen levels (4 weeks) did not lead to altered fat storage, although it
did affect post-prandial circulating triglyceride levels [44]. By contrast,
short-term (4 weeks) suppression of testosterone levels in men led to
increased storage of meal-derived fatty acids in the glutealefemoral
fat depot [45]. The effects of gonadal hormones on fat depot devel-
opment and metabolism are likely influenced by numerous variables,
including hormone levels and estrogen and androgen receptor levels
[46].
Beyond the well-established roles of gonadal hormones, accumulating
evidence supports a key role for the sex chromosomes in the deter-
mination of sex differences in adiposity. The presence of XX chro-
mosomes in females and XY chromosomes in males determines the
development of ovaries or testes, respectively [47]. Specifically, the
SRY (sex-determining region Y) gene present on the Y chromosome
encodes a transcription factor that initiates testes development in XYhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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embryos, and subsequent elaboration of testicular hormones. Lack of
an SRY gene in an embryo (due to XX chromosomes or deletion of the
SRY gene) leads to the development of ovaries and production of
ovarian hormones. Sex differences in body composition are evident
prior to exposure to gonadal hormones. For example, during human
and mouse embryonic development, male fetuses show a larger size
than female fetuses even before gonadal differentiation [48,49].
Children continue to exhibit sex differences in body weight at birth,
with male babies typically weighing more than female babies, in part
due to greater body length and larger head circumference [50]. Male/
female differences in height, weight, lean mass, and total body fat
mass persist in childhood, prior to puberty [51].
One approach to study effects of sex chromosome complement is to
assess adiposity and related traits in individuals with Klinefelter syn-
drome (XXY) or Turner syndrome (XO). Klinefelter syndrome is the most
common sex chromosome disorder, occurring in approximately 1 in
660 births, and is a frequent cause of infertility and hypogonadism in
men [52]. These men typically present with a eunuchoid body habitus,
small testes, hypergonadotrophic hypogonadism, and infertility [53].
Individuals with Klinefelter have been shown to have an almost five-
fold higher incidence of developing metabolic syndrome [54],
defined as the occurrence of at least three of the following: abdominal
obesity, elevated fasting glucose levels, elevated triglyceride levels,
reduced high-density lipoprotein levels, and hypertension [55]. XXY
men also have increased risk of insulin resistance and type 2 diabetes
[56,57]. It is possible that the increased risk for metabolic syndrome
and insulin resistance in XXY individuals is secondary to increased
abdominal obesity, which, in turn, may stem from hypogonadism and
low testosterone levels in XXY men [54,56,58]. Importantly, studies of
prepubertal XXY boys (mean age < 11) identified increased body fat
mass and/or waist circumference prior to an influence of altered
gonadal hormone levels at puberty [59,60]. This suggests that XXY sex
chromosome complement itself may affect adiposity and related
metabolic traits.
Turner syndrome (TS) is the most common sex chromosome abnor-
mality affecting females, with an incidence of 1 in 2500e3000 live
births (8). TS women are characterized by short stature, a webbed
neck, and sexual infantilism with gonadal dysgenesis [61,62]. TS
women also have congenital heart defects, which may predispose to
heart disease that develops independent of metabolic factors [63].
Relevant to metabolic disease, XO women have dramatically reduced
gonadal hormone levels [64]. Since estrogens and progestins in normal
pre-menopausal women confer protection against abdominal obesity
and insulin resistance and promote fat storage in glutealefemoral fat
pads [40], the low levels of these hormones may obscure any direct
effects of the XO chromosome complement on metabolism. Consistent
with low gonadal hormone levels, TS women have a four-fold increase
in risk for type 2 diabetes and a three-fold increase in overall mortality
[65]. A potential role for early fetal programming has been proposed to
contribute to the metabolic abnormalities in TS women, which is
consistent with low birth weight and high body weight in adult life [66].
Other data show a role for sex chromosome number, as described
below.
The confounding effect of aberrant gonadal hormone levels in XO
women makes it difficult to reach conclusions about the influence of
the sex chromosome complement on metabolic homeostasis in these
individuals. From an experimental perspective, it would be valuable to
compare the effects of a single X chromosome in TS women to in-
dividuals with two X chromosomes on a background of similarly low
gonadal hormones. The latter condition is approximated in XX women
with primary ovarian insufficiency (POI) and corresponding low gonadalMOLECULAR METABOLISM 15 (2018) 35e44  2018 The Authors. Published by Elsevier GmbH. This is an open ac
www.molecularmetabolism.comhormone levels. A comparison of lipid profiles in women with TS and
POI (age- and body mass-matched) two weeks after halting estrogen
replacement therapy showed that TS women had a more atherogenic
lipid profile [67]. Because both TS and POI women had reduced
gonadal hormone contributions compared to normal women, and were
matched for lifestyle and body composition, investigators have hy-
pothesized that some metabolic effects in TS women may be attributed
to the altered X chromosome dosage [57,67]. It is important to
recognize, however, that comparisons between TS and POI women
remain confounded by the fact that TS individuals have aberrant
development and impaired ovarian hormone secretion through their
entire life, whereas POI women are normal during development and
are only affected later in life.
Additional sex chromosome anomalies occurring in humans include
Swyer syndrome and Triple X syndrome. Swyer syndrome, also known
as XY gonadal dysgenesis is a rare disorder of sexual development in
which 46,XY individuals have impaired gonadal tissue development
[68]. These individuals present externally as females but fail to develop
functional ovaries and do not undergo puberty unless treated with
hormone therapy. This condition can be due to SRY gene mutations
(thought to underlie 10e20% of cases) or mutations in other genes
[68]. The Triple X syndrome (47, XXX) is characterized by variable
presentation of phenotypes such as tall stature, cognitive and
behavioral disorders and dental issues [69]. At present, no studies
have been reported with adequate sample sizes of either Swyer or XXX
syndromes to analyze effects of these conditions on adiposity or
related metabolic traits. It should be noted that in XO, XX, and XXX
cells, X chromosome inactivation silences most genes on all but a
single X chromosome. The occurrence of abnormalities in both Turner
(XO) and XXX syndromes therefore supports the view that X chromo-
some dosage is important, despite the process of inactivation of all but
one X. Possible reasons for the importance of having exactly two X
chromosomes is discussed in sections 5 and 8.
5. A ROLE FOR XX CHROMOSOME DOSAGE IN SEX
DIFFERENCES IN ADIPOSITY
Conclusive studies of metabolic changes in XXY men and XO women
have been hampered by the lack of suitable control groups with similar
gonadal hormone levels, by limited statistical power due to small
cohorts, and by heterogeneity among individuals in the genetic and
environmental factors that influence obesity. The use of mouse models
makes it possible to overcome some of these limitations and to
evaluate the relative contributions of sex chromosomes and gonadal
hormones to sex differences.
A traditional approach used in mouse models to identify the cause of
sex differences is to assess the action of gonadal hormones after
puberty [70]. Adult female and male mice are gonadectomized and
assessed to find whether the original sex difference is eliminated. If so,
replacement of hormones by an implanted pump or daily injection is
performed and mice observed to determine if the original sex differ-
ence is restored. Follow-up studies may include identification of the
hormone receptor that mediates the effect, which can be done through
chemical or genetic inhibition of hormone receptor function. For sex
differences that occur before puberty, or which are not altered by
gonadectomy, the role of the surges in testosterone that occur pre- or
epostnatally may be studied. For meaningful performance and inter-
pretation of studies that manipulate gonadal hormones, many factors
must be considered and are reviewed elsewhere [70]. If gonadal
hormone differences cannot fully explain a sex difference, the potential
effect of sex chromosome complement should be considered.cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 37
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of gonadal hormones as well as sex chromosomes is the Four Core
Genotypes (FCG) mouse. The model involves the relocation of the Sry
gene, which promotes the development of testes, from the Y chro-
mosome to an autosome such that gonadal sex can segregate inde-
pendently from sex chromosome complement [70,71]. The position of
the Sry gene on an autosome does not alter the prenatal or adult
androgen levels [72]. Studies performed with FCG mice involve the
comparison of four genotypes, which shuffle the chromosomal and
gonadal components of sex to generate XX mice with either ovaries or
testes and XY mice with either ovaries or testes (referred to, respec-
tively, as XX F, XX M, XY F, and XY M). A two-by-two comparison of
these four genotypes allows identification of effects that are dictated by
either gonadal type or sex chromosome type (Figure 1). To eliminate
the contribution of circulating gonadal hormones, the FCG mice are
often studied after gonadectomy as adults.
Using the FCG model, effects of sex chromosome complement on
several metabolic traits have been identified, including obesity, plasma
lipid profile, food intake, and hypertension [73e77]. In C57BL/6 FCG
mice that were gonadectomized as adults to remove acute effects of
gonadal hormones, mice with XX versus XY chromosomes (regardless
of male or female gonads present originally) gained weight more
rapidly on a chow or high-fat diet, and accumulated greater body fat,
particularly in the inguinal subcutaneous fat depot (Figure 2) [73].
Increased weight gain in XX compared to XY mice was promoted, at
least in part, by enhanced food intake by XX mice, specifically during
the light phase of the circadian cycle [74]. As nocturnal animals, mice
consume approximately 70% of their calories during the dark phase,
and they rest and snack (30% of total calories) during the light phase.
The enhanced food intake by XX mice in the light phase was due to
anticipatory eating beginning about 1.5 h before their XY counterparts
[74]. In addition to increased adipose tissue accumulation, XX mice fed
a high-fat diet for 16 weeks developed obesity-related conditions such
as fatty liver, elevated total blood cholesterol levels, and elevated in-
sulin levels [73]. It is likely that these metabolic disturbances are
secondary to the enhanced fat accumulation in XX mice fed a high-fat
diet since they are not seen in XX mice fed a chow diet.Figure 1: The Four Core Genotypes (FCG) mouse model. The FCG mouse model uncouples
Traits that are influenced by gonadal hormones (or other effects conferred by ovaries or tes
with testes, whereas the groups with ovaries and testes differ from one another. Conversel
animals with ovaries or testes, and XY animals with ovaries or testes, and the XX and X
Ref. [71].
38 MOLECULAR METABOLISM 15 (2018) 35e44  2018 The Authors. Published by Elsevier GmbH. TData from the FCG mice clearly showed an effect of XX compared to XY
chromosomes on adiposity and obesity-related morbidities. But these
studies alone did not distinguish between an effect of X chromosome
dosage (two versus one X) or an effect of the presence or absence of
the Y chromosome. Analysis of mouse models with additional sex
chromosome genotypes made it possible to identify the relevant sex
chromosome effect. By making use of an unusual Y chromosome with
sequence duplications in the pseudoautosomal region (known as the
XY* model, [71]), mice with XX, XY, XO and XXY chromosomes were
assessed for body weight and adiposity. The results showed that the
presence of two X chromosomes (XX and XXY mice) led to higher body
weight/fat than one X chromosome (XY and XO); the presence of the Y
chromosome did not have an influence (Figure 2) [73].
6. SEX CHROMOSOME EFFECTS ON LIPID LEVELS
Beyond adiposity, sex chromosome complement in mouse and
humans influences plasma lipid levels. Elevated levels of total plasma
cholesterol levels and of specific lipoprotein subclasses have well-
known epidemiological associations with cardiovascular disease. At
a general level, elevations in low-density lipoproteins (LDL) and re-
ductions in high-density lipoprotein (HDL) levels are associated with
increased cardiovascular disease risk [78]. Current results suggest
that specific components of the lipid profile are influenced inde-
pendently by X chromosome dosage, presence of the Y chromosome,
and gonadal hormones; the sex differences observed are likely a
composite of all of these contributions. For example, gonadal hor-
mones appear to regulate lipoprotein metabolism, as pre-
menopausal women tend to have higher HDL levels and lower LDL
levels than men, and post-menopause, lipoprotein profiles become
more similar to men (reviewed in Ref. [18]). Evidence for Y chro-
mosome effects come from the demonstration that genetic variations
in the Y chromosome are associated with lipoprotein profiles in men
[79,80] and mice [81]. In addition, studies with the FCG mouse model
revealed effects of X chromosome dosage on HDL cholesterol levels,
whereas gonadal hormones had effects on triglyceride and fatty acid
levels [18,77].chromosomal sex from gonadal sex to reveal contributions of each to traits of interest.
tes) appear similar between XX and XY mice with ovaries, and between XX and XY mice
y, traits that are influenced by sex chromosome complement appear similar between XX
Y groups differ from one another. For information on the derivation of FCG mice, see
his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 2: Summary of the influence of sex chromosome complement on adiposity and related traits in mice and humans. (A) Studies of the Four Core Genotypes mice revealed
that the presence of XX chromosomes leads to increased body weight, fat mass and related morbidities compared to XY mice (all mice gonadectomized as adults to remove acute
effects of gonadal hormones). (B) Studies of XY* mice determined that the presence of two X chromosomes promotes greater body weight and fat mass than those with one X
chromosome, with no evident effect of the Y chromosome (all mice gonadectomized as adults). (C) XXY compared to XY men show greater abdominal fat, insulin resistance and
related metabolic abnormalities. XXY men also have reduced gonadal hormone levels. (D) XO compared to XX women show increased body fat, but also suffer from developmental
and hormonal abnormalities. Data are summarized from studies cited in the main text.7. SEX DIFFERENCES IN INFLAMMATION AND
IMMUNOMETABOLISM
Obesity is an inflammatory disease, and it has been shown in mice that
males and females differ in the inflammatory response that occurs in
diet-induced obesity [82]. Sex differences in the inflammatory response
that is elicited by high-fat diet in mice include increased adipose tissue
infiltration with M1 (CD11cþ) macrophages in males, but M2 (CD11ce)
macrophages in females, and increased levels of inflammatory cyto-
kines in males compared to females [83]. Bone marrow transplantMOLECULAR METABOLISM 15 (2018) 35e44  2018 The Authors. Published by Elsevier GmbH. This is an open ac
www.molecularmetabolism.comstudies demonstrated that the sex-dependent inflammatory response is
related to a cell-intrinsic sexual dimorphism in the composition or
activation of hematopoietic stem cell populations [83].
Autoimmune diseases are among the most strongly sex-biased of all
diseases, and 80% of autoimmune patients are women [84]. Obesity is
a risk factor for autoinflammatory and autoimmune diseases including
systemic lupus erythematosus, type 1 diabetes, rheumatoid arthritis,
and psoriasis [85]. Likely mechanistic links between obesity and
autoimmune dysfunction include sex-dependent alterations in the
levels of adipokines produced by adipocytes (e.g., leptin, resistin,cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 39
Reviewadiponectin, visfatin), and production of inflammatory cytokines (e.g.,
tumor necrosis factor a, interleukin-6). Both gonadal hormones and X
chromosome dosage have been implicated in the female bias in
autoimmune disease [86]. Consistent with effects of gonadal hor-
mones, sex bias in autoimmune disease is more evident after puberty.
Estrogens and androgens exert distinct influences over cytokine pro-
duction and T cell differentiation. Testosterone is suppressive of both
the adaptive and innate immune response, whereas estrogen may
promote inflammatory responses [87,88]. An interaction between early
life gut microbial composition and gonadal hormone levels has been
identified in type 1 diabetes in the non-obese diabetic mouse [89]. In
this model, the commensal bacteria in the gut elevated serum
testosterone levels in males, which was protective against type 1
diabetes. The transfer of gut microbial populations from adult males to
immature females resulted in elevated testosterone levels, reduced
pancreatic islet inflammation, and protection against type 1 diabetes.
These effects were dependent on androgen receptor activity.
In addition to the effects of gonadal hormones on autoimmunity, sex
chromosome complement likely plays a role. Using the FCG mouse
model to study experimental autoimmune encephalomyelitis (relevant
to multiple sclerosis) and spontaneous lupus, disease was more severe
in XX compared to XY mice with female gonads [90e92]. Studies of
DNA methylation suggested that maternal versus paternal imprinting of
X chromosome genes could contribute to the sex differences in
experimental immune encephalitis [93]. Y chromosome gene dosage
has also been implicated in autoimmune disease. For example, natural
genetic variation in the copy number of multicopy genes on the Y
chromosome is associated with susceptibility to experimental allergic
encephalomyelitis and experimental myocarditis in the mouse [94].
Studying consomic Y chromosome mouse strains (which possess the Y
chromosome from one inbred mouse strain on the background of
another inbred strain) revealed a link between copy number of two
specific Y chromosome genes and gene expression in immune cells
[94]. The role of Y chromosome sequences as a trans-acting regulator
of gene expression may contribute to the sexual dimorphism in
autoimmune disease. However, interpretation of such findings is
complex. On one hand, they could indicate that the Y chromosome mayFigure 3: Sex differences in expression of a representative gene that escapes X chromoso
demethylase and escapes inactivation leading to increased gene expression levels across m
GTEx project [103] and downloaded from gtexportal.org. Ad (SC), subcutaneous adipose tis
Hippo, hippocampus; Hypo, hypothalamus, Colon (Sig), sigmoidal colon; Colon (Trans), tran
Atr, atrium; Vent, ventricle; Skel Muscle, skeletal muscle. Right, Hepatic mRNA levels f
Refs. [18,77]). Expression levels in XX mice with ovaries (F) or testes (M) are higher than in
of Kdm6a escape from X chromosome inactivation.
40 MOLECULAR METABOLISM 15 (2018) 35e44  2018 The Authors. Published by Elsevier GmbH. Tbe partly responsible for conferring the observed sex differences in
susceptibility to autoimmune disease. On the other, it has been sug-
gested that gene expression from the Y chromosome acts as a “bal-
ancer” to the effects of the X chromosome. In this view, expression of
genes from the Y chromosome makes males more like females, such
that altered Y chromosome gene dosage may tip the balance and
influence sex differences in autoimmune diseases and other traits [95].
8. POTENTIAL MECHANISMS FOR SEX CHROMOSOME
EFFECTS ON METABOLISM
There are multiple mechanisms that may underlie the effects of sex
chromosome complement on obesity, lipid metabolism, autoimmu-
nity, and other traits. The presence of XX or XY chromosomes pro-
foundly influences the developmental path and sets up a lifelong
difference between sexes in the levels of gonadal hormones. Both
gonadal hormones and sex chromosomes influence gene expression,
which likely underlies phenotypic differences observed between
males and females. Early studies of gene expression in male and
female mice from a genetic intercross of two inbred strains revealed
male/female differences in gene expression in adipose tissue, liver,
and skeletal muscle (thousands of genes) as well as brain (hundreds
of genes) [96]. This study also provided evidence for the global
regulation of subsets of the genes that were differentially expressed
between the sexes. A subsequent study in the same mouse intercross
population revealed correlations between body fat and lipid levels and
sex-specific gene expression modules in adipose tissue and liver;
many of the modules were shown to be regulated by gonadal hor-
mones [97]. Additional studies have revealed gonadal hormone in-
fluences on transcriptional profiles of subcutaneous and visceral
adipose tissue depots [31,36].
Mouse models have also revealed effects of sex chromosomes on gene
expression. Of note, sex chromosomes influence the expression of
hundreds of autosomal genes and some of these effects are modulated
by the presence of the testis-determining gene, Sry [98e100].
MicroRNAs (miRNAs), which modulate gene expression levels by
interacting with specific mRNA species to increase their degradation orme inactivation in humans and mice. Left, The X-linked KDM6A gene encodes a histone
any human tissues. Data shown are transcripts per million (TPM) in RNA-seq data of the
sue; Ad (V), visceral adipose tissue; Cere, cerebellum; Cor, cortex; Fr Cor, frontal cortex,
scending colon; Esoph (Muc) mucosal esophagus, Esoph (musc), muscular esophagus;
or the mouse Kdm6a gene in Four Core Genotypes mice determined by qPCR (from
XY mice with ovaries or testes, demonstrating a sex chromosome effect, and reflective
his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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interfere with translation, are also influenced by sex. Using the FCG
mouse model to parse effects of gonadal and chromosomal sex, the
overall miRNA expression profile showed a bias toward higher
expression in male compared to female gonadal adipose tissue [101].
This bias was normalized after gonadectomy, indicating a role for
circulating gonadal hormones in modulating miRNA levels. In mice fed
a high-fat diet, miRNA levels were higher in mice with XX versus XY
chromosome complement. Thus, there is a compound effect of
gonadal hormones and sex chromosomes on miRNA expression, and
presumably, on the mRNAs regulated by these miRNAs.
Recent analysis of human transcriptome data from the GTEx project is
consistent with mouse data in detecting thousands of genes that are
differentially expressed in male and female tissues [102]. The GTEx
project includes RNA-seq data from>50 tissues from hundreds of men
and women [103]. Most genes that were found to have sex differences
in expression levels exhibited these differences in one or a few tissues
[102]. By contrast, 16 X-chromosome genes had sex differences across
at least six tissues, suggesting widespread effects. Of tissues found in
both males and females, the most sex-differentiated gene expression
occurred in breast tissue, consistent with the sexually dimorphic
physiology and structure of breast tissue [102].
It is straightforward to imagine how gonadal hormones could influence
gene expression across the genome, but less intuitive to understand how
differences in sex chromosome complement could alter expression of
genes on autosomes. The presence of two X chromosomes in a cell
confers unique properties that are not present in an XY cell. In XX cells, one
X chromosome is transcriptionally silenced in cells outside of the germline
to reduce the expression of most X chromosome genes so that levels are
comparable between XX and XY cells. However, some X chromosome
genes “escape” inactivation and remain transcriptionally active on both X
chromosomes in XX cells. Importantly, genes that escape X inactivation
are largely conserved between human and mouse [104e108].
The X inactivation escapee genes exhibit increased expression in tis-
sues from women compared to men, including in metabolic tissues
such as adipose tissue and liver. An expression profile in men and
women for a representative X chromosome escapee gene (KDM6A) is
shown in Figure 3. The corresponding mouse gene (Kdm6a) exhibits
increased expression levels in XX compared to XY FCG mice, showing
that this effect is determined by sex chromosome complement rather
than gonadal hormones (Figure 3). It is estimated that 3e6% of mouse
X chromosome genes escape inactivation, and these same genes plus
others (approximately 15% of X chromosome genes) escape inacti-
vation in humans [104e108]. Some X escapee genes have partner
genes that were retained on the Y chromosome, and escape from
inactivation may help normalize expression of these genes between XX
and XY cells. However, many more X chromosome genes escape
inactivation than have partners on the Y chromosome [107]. The X
escapee genes encode proteins that may influence gene expression
broadly, including histone modifying enzymes, translation initiation
proteins, and RNA helicases, to name a few. Differences also exist
between XX and XY cells due to parent-of-origin imprinting. Genomic
imprinting is the heritable DNA or histone methylation at specific re-
gions of chromosomes that leads to transcriptional silencing. Imprints
are established in the germline of the mother or father and passed to
offspring such that the allele from only one parent will be expressed in
the offspring. XX cells receive an X chromosome from both father and
mother, whereas an XY cell receives an X exclusively from the mother.
Thus, only XX cells undergo paternal X chromosome imprinting, which
can lead to differences in gene expression in XX compared to XY cells.
For more extensive discussion of these mechanisms, the reader is
referred to excellent recent reviews [47,71].MOLECULAR METABOLISM 15 (2018) 35e44  2018 The Authors. Published by Elsevier GmbH. This is an open ac
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We propose that we will not fully understand many aspects of
metabolism until we understand sex differences in metabolism. This
includes differences between women and men in the risk and
development of obesity and in the manifestation of related morbid-
ities. The identification of these differences may reveal how one sex
is protected from specific disease outcomes compared to the other
and suggest new prevention and treatment possibilities for both
sexes. Research approaches that consider the components of
sex-biasing effectsdincluding differences dictated by gonad type
and by sex chromosome complementdwill provide the most com-
plete understanding. The study of mouse models with unique sex
chromosome combinations and humans with naturally occurring sex
chromosome variations have already begun to hint at important
effects of sex chromosomes on obesity, lipid metabolism, and
inflammation. Further understanding will require a more complete
elucidation of the molecular differences imparted by presence of XX
or XY chromosome complements. The current recognition of sex
as an important biological variable to be considered in research
[109e111] will likely provide new (and welcome) motivation to push
the field forward.
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